Skip over navigation
The Hospital
Research
Support Us
Ottawa Hospital Research Institute
Home
Français
Directions & Maps
Contact Us
About Us
Vision and Strategic Directions
Board Chair and CEO Message
Leadership Team
Annual Reports
Facilities
Research Data Management
Equity, Diversity and Inclusion
Wellness
Our Research
Priorities, Programs and Diseases
Researcher Profiles
National Research Networks
Scientific Publications
Research Awards
Technology Transfer
Industry Sponsored Research
Responsible Innovation
For Students & Fellows
News & Events
Newsroom
Seminars & Events
Career Opportunities
For Patients
News & Events
Home
>
News & Events
>
Newsroom
Bookmark or Share
Display Options
Display Options
+
Increase
/
-
Decrease
font size
High contrast version
Printer-friendly version
Newsroom
Seminars & Events
Newsroom
Genetic test could help tailor colorectal cancer therapy
January 15, 2014
New research led by Dr. Derek Jonker could help improve a genetic test to predict which colorectal cancer patients are likely to benefit from a targeted therapy called cetuximab. Previous research by Dr. Jonker showed that a gene called K-RAS could partially predict cetuximab benefit, and testing for this gene is now standard in Canada and the U.S. Dr. Jonker’s new research, published in the
British Journal of Cancer
, shows that adding another gene called Epiregulin may be able to further improve the test. Further research is needed, however, this work represents an important step in the development of personalized medicine for cancer.
Funders:
Canadian Cancer Society (NCIC Clinical Trials Group), ImClone Systems, Bristol-Meyers Squibb
About the Ottawa Hospital Research Institute
The Ottawa Hospital Research Institute (OHRI) is the research arm of The Ottawa Hospital and is an affiliated institute of the University of Ottawa, closely associated with the university’s Faculties of Medicine and Health Sciences. OHRI includes more than 1,700 scientists, clinical investigators, graduate students, postdoctoral fellows and staff conducting research to improve the understanding, prevention, diagnosis and treatment of human disease.
Media contact
Jennifer Ganton
Director, Communications and Public Relations
Ottawa Hospital Research Institute
613-798-5555 x 73325
613-614-5253 (cell)
jganton@ohri.ca